Westpac Banking Corp’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,683
Closed -$1.15M 804
2022
Q3
$1.15M Hold
4,683
0.02% 591
2022
Q2
$1.16M Hold
4,683
0.02% 640
2022
Q1
$1.55M Hold
4,683
0.02% 623
2021
Q4
$1.68M Buy
4,683
+171
+4% +$57.8K 0.02% 603
2021
Q3
$1.47M Hold
4,512
0.02% 646
2021
Q2
$1.41M Hold
4,512
0.01% 690
2021
Q1
$1.44M Hold
4,512
0.02% 623
2020
Q4
$1.46M Hold
4,512
0.02% 634
2020
Q3
$1.25M Buy
4,512
+1,764
+64% +$508K 0.02% 622
2020
Q2
$664K Hold
2,748
0.01% 729
2020
Q1
$399K Sell
2,748
-27,790
-91% -$4.61M 0.01% 748
2019
Q4
$5.21M Sell
30,538
-783
-2% -$145K 0.07% 377
2019
Q3
$5.57M Buy
31,321
+18,967
+154% +$4.1M 0.08% 339
2019
Q2
$3.22M Sell
12,354
-1,418
-10% -$376K 0.05% 385
2019
Q1
$3.93M Buy
13,772
+150
+1% +$49.9K 0.06% 341
2018
Q4
$4.43M Sell
13,622
-2,495
-15% -$867K 0.08% 348
2018
Q3
$7.25M Buy
16,117
+1,775
+12% +$700K 0.12% 232
2018
Q2
$5.87M Buy
14,342
+5,536
+63% +$2.01M 0.11% 258
2018
Q1
$2.56M Buy
+8,806
New +$2.23M 0.05% 363

Other funds holding ABMD

Westpac Banking Corp's ABMD Position: Q4 2022 in Review

Westpac Banking Corp sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,683 shares — an estimated $1.15M sold.

Westpac Banking Corp first reported a position in ABMD in Q1 2018 and held it in 19 quarters. The position peaked at $7.25M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Westpac Banking Corp reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Westpac Banking Corp sold 4,683 Abiomed Inc shares in Q4 2022, an estimated $1.15M.
  • Westpac Banking Corp first reported a position in Abiomed Inc in Q1 2018 and held it in 19 quarters.
  • Westpac Banking Corp's Abiomed Inc position peaked at $7.25M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Westpac Banking Corp's 13F filing for Q4 2022, filed 6 Feb 2023.